Back
EyePoint Pharmaceuticals Stock Predictions
Sponsored
EYPT
Sponsored
Invest. Do Good. Get Rewarded. Just $0.25/Share!
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Buy
55
EYPT
EyePoint Pharmaceuticals
Last Price:
9.28
Seasonality Move:
28.93%
7 Day Trial
ALL ACCESS PASS
$
7
Start Investing Smarter Unlock Louis Navellier's Stock Grader for free
Louis' clients have paid up to $30,000 for these insights - now you can try it at no cost.EyePoint Pharmaceuticals Stock Forecast
- Over the next 52 weeks, EyePoint Pharmaceuticals has on average historically risen by 21.6% based on the past 19 years of stock performance.
- EyePoint Pharmaceuticals has risen higher in 9 of those 19 years over the subsequent 52-week period, corresponding to a historical accuracy of 47.37%
-
Is EyePoint Pharmaceuticals Stock Undervalued?
The current EyePoint Pharmaceuticals [EYPT] share price is $8.35. The Score for EYPT is 55, which is 10% above its historic median score of 50, and infers lower risk than normal. - EYPT is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
Will EyePoint Pharmaceuticals Stock Go Up Next Year?
- Over the next 52 weeks, EyePoint Pharmaceuticals has on average historically risen by 21.6% based on the past 19 years of stock performance.
EyePoint Pharmaceuticals Stock Rating
Buy
55
EyePoint Pharmaceuticals (EYPT)
is a Buy
Is EyePoint Pharmaceuticals overpriced?
- EyePoint Pharmaceuticals has risen higher in 9 of those 19 years over the subsequent 52-week period, corresponding to a historical accuracy of 47.37%
EyePoint Pharmaceuticals Stock Price History
Stock Information
Stock Info
Exchange:
NASDAQ
Country:
United States
Industry:
Pharmaceuticals
Sector:
Health Care
Type:
stock
Website:
eyepointpharma.com
52-Week Data
52-Week High:
30.99
52-Week Low:
5.86
Prediction Charts
Market Cap:
569.9M
Price in USD:
8.35
Volume:
2.48M
Beta:
1.90
Technical Analysis
SMA50:
9.77
SMA100:
9.32
SMA200:
13.55
52-Wk Change:
36.44%
Stock Predictions
-
Is EyePoint Pharmaceuticals stock public?
Yes, EyePoint Pharmaceuticals is a publicly traded company. -
What is the EyePoint Pharmaceuticals stock quote today?
The EyePoint Pharmaceuticals stock price is 8.35 USD today. -
How to buy EyePoint Pharmaceuticals stock online?
You can buy EyePoint Pharmaceuticals shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.
14-Day Historical Data
Date | Opening | Closing | Minimum | Maximum |
---|---|---|---|---|
Nov-4 | 12.06 | 11.70 | 12.10 | 11.30 |
Nov-5 | 11.53 | 11.61 | 11.71 | 11.06 |
Nov-6 | 11.99 | 12.08 | 12.37 | 11.76 |
Nov-7 | 12.41 | 11.59 | 12.50 | 11.35 |
Nov-8 | 11.59 | 11.63 | 11.77 | 11.26 |
Nov-11 | 11.73 | 12.00 | 12.23 | 11.64 |
Nov-12 | 11.86 | 11.11 | 11.97 | 11.09 |
Nov-13 | 11.29 | 10.76 | 11.39 | 10.46 |
Nov-14 | 10.80 | 10.49 | 10.83 | 10.26 |
Nov-15 | 10.56 | 9.17 | 10.56 | 9.05 |
Nov-18 | 9.17 | 8.58 | 9.31 | 8.56 |
Nov-19 | 8.42 | 9.21 | 9.40 | 8.25 |
Nov-20 | 9.14 | 8.96 | 9.16 | 8.70 |
Nov-21 | 9.00 | 8.35 | 9.07 | 8.25 |
EyePoint Pharmaceuticals Earnings
EyePoint Pharmaceuticals Earnings Report: Per Share EyePoint Pharmaceuticals Earnings Q1 Q2 Q3 and Q4 last year and next year.
EyePoint Pharmaceuticals Forecast Revenue Growth
EyePoint Pharmaceuticals Stock Analysis: Historical quarterly revenues per share for EyePoint Pharmaceuticals and historical quarterly revenue growth:
- Analysts estimate an earnings decrease this quarter of $0.09 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.31 per share, and a decrease next year of $0.31 per share.
* EyePoint Pharmaceuticals stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.